|Summary of Trump Administration Drug Pricing and AKS Rulemakings and Implications for Life Sciences Companies and Health Care Providers||November 25, 2020||Brian P. Carey, Ross Margulies, Erik L. Schulwolf, Haider David Andazola||Healthcare Alert|
|Department of Health and Human Services Issues Request for Information on COVID-19 Best Practices||November 24, 2020||Eli Greenspan||Healthcare Alert|
|Reminder: Renewal and Notice Filing Fees for Investment Advisers Due by December 14, 2020||November 24, 2020||Robert G. Sawyer, Ayah K. Zaidi||The Foley Adviser|
|New Guidelines for EU-US Data Transfers||November 19, 2020||Christopher Escobedo Hart, Stephen Stich||Privacy and Data Security Alert|
|Five ways the Biden Administration Could Rescind or Reverse the Trump Administration’s Regulatory Actions||November 13, 2020||Tad Heuer, Kelly Caiazzo, Aaron Lang||White Paper|
|Summary of Supreme Court Oral Arguments in California v. Texas||November 12, 2020||Tad Heuer, Ross Margulies||White Paper|
|The Health Care Priorities of the Biden Harris Administration and Post Election Outlook for the 117th Congress||November 11, 2020||Thomas Barker, Brian P. Carey, Paul T. Kim, Ross Margulies||White Paper|
|FTC Invites Public Comments on Proposed Changes to HSR Rules||November 9, 2020||Austin A.B. Ownbey||Business Alert|
|Product Liability Update: October 2020||November 5, 2020||David R. Geiger, Richard G. Baldwin, Peter Ellis||Product Liability Update|
|Governor Baker Issues New Measures To Curb Rising COVID-19 Cases, Hospitalizations in Mass.||November 3, 2020||Tad Heuer||Business Alert|
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.